Latest Issue
-
Lorazepam Treatment May Be Linked to Worse Outcomes for Pancreatic Cancer Patients
Philadelphia, PA—Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research. -
Generic and Biosimilar Drugs Generate $408 Billion in Savings for America’s Patients and Healthcare System in 2022
Washington, DC—On September 6, 2023, the Association for Accessible Medicines (AAM), the leading trade association for generic and biosimilar manufacturers, released its 2023 U.S. Generic & Biosimilar Medicines Savings Report highlighting the value of generic and biosimilar medicines. -
Improving Diversity in Clinical Trials
Chicago, IL—It is well documented that clinical trials thus far have for the most part excluded underserved populations, and that means the results of these trials cannot be generalized to society at large.